| Title | Pharmacogenomics Journal |
| Abbreviation | Pharmacogenomics J. |
| Publication Type | Journal |
| Subject Area, Categories, Scope | Pharmacology (Q2); Genetics (Q3); Molecular Medicine (Q3) |
| h-index | 99 |
| Overall Rank/Ranking | 8195 |
| SCImago Journal Rank (SJR) | 0.694 |
| Impact Score | 2.86 |
| Publisher | Springer Nature |
| Country | United Kingdom |
| ISSN | 1470269X, 14731150 |
| Best Quartile | Q2 |
| Coverage History | 2001-2024 |
The Pharmacogenomics Journal is a print and electronic journal, which is dedicated to the rapid publication of original research on pharmacogenomics and its clinical applications.
Key areas of coverage include:
Effects of genetic variability on drug toxicity and efficacy
Identification and functional characterization of polymorphisms relevant to drug action
Pharmacodynamic and pharmacokinetic variations and drug efficacy
Integration of new developments in the genome project and proteomics into clinical medicine, pharmacology, and therapeutics
Clinical applications of genomic science
Identification of novel genomic targets for drug development
Potential benefits of pharmacogenomics.
Pharmacogenomics Journal is a journal covering the technologies/fields/categories related to Pharmacology (Q2); Genetics (Q3); Molecular Medicine (Q3). It is published by Springer Nature. The overall rank of Pharmacogenomics Journal is 8195. According to SCImago Journal Rank (SJR), this journal is ranked 0.694. SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come. SJR acts as an alternative to the Journal Impact Factor (or an average number of citations received in last 2 years). This journal has an h-index of 99. The best quartile for this journal is Q2.
The ISSN of Pharmacogenomics Journal journal is 1470269X, 14731150. An International Standard Serial Number (ISSN) is a unique code of 8 digits. It is used for the recognition of journals, newspapers, periodicals, and magazines in all kind of forms, be it print-media or electronic. Pharmacogenomics Journal is cited by a total of 367 articles during the last 3 years (Preceding 2024).
The Impact IF 2024 of Pharmacogenomics Journal is 2.86, which is computed in 2025 as per its definition. Pharmacogenomics Journal IF is increased by a factor of 0.28 and approximate percentage change is 10.85% when compared to preceding year 2023, which shows a rising trend. The impact IF, also denoted as Journal impact score (JIS), of an academic journal is a measure of the yearly average number of citations to recent articles published in that journal. It is based on Scopus data.
Impact IF 2024 of Pharmacogenomics Journal is 2.86. If the same upward trend persists, Impact IF may rise in 2025 as well.
| Year | Impact IF |
|---|---|
| 2025/2026 | Coming Soon |
| 2024 | 2.86 |
| 2023 | 2.58 |
| 2022 | 2.84 |
| 2021 | 3.23 |
| 2020 | 3.09 |
| 2019 | 2.90 |
| 2018 | 3.36 |
| 2017 | 3.65 |
| 2016 | 3.88 |
| 2015 | 4.27 |
| 2014 | 4.77 |
Pharmacogenomics Journal has an h-index of 99. It means 99 articles of this journal have more than 99 number of citations. The h-index is a way of measuring the productivity and citation impact of the publications. The h-index is defined as the maximum value of h such that the given journal/author has published h papers that have each been cited at least h number of times.
The ISSN of Pharmacogenomics Journal is 1470269X, 14731150. ISSN stands for International Standard Serial Number.
An ISSN is a unique code of 8 digits. It is used for the recognition of journals, newspapers, periodicals, and magazines in all kind of forms, be it print-media or electronic.
The overall rank of Pharmacogenomics Journal is 8195. According to SCImago Journal Rank (SJR), this journal is ranked 0.694. SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come.
| Year | SJR |
|---|---|
| 2025/2026 | Coming Soon |
| 2024 | 0.694 |
| 2023 | 0.659 |
| 2022 | 0.621 |
| 2021 | 0.764 |
| 2020 | 0.804 |
| 2019 | 0.981 |
| 2018 | 1.096 |
| 2017 | 1.320 |
| 2016 | 1.377 |
| 2015 | 1.449 |
| 2014 | 1.648 |
| Year | Ranking |
|---|---|
| 2025/2026 | Coming Soon |
| 2024 | 8195 |
| 2023 | 8053 |
| 2022 | 8244 |
| 2021 | 6125 |
| 2020 | 6014 |
| 2019 | 4455 |
| 2018 | 3797 |
| 2017 | 2848 |
| 2016 | 2732 |
| 2015 | 2546 |
| 2014 | 1964 |
Pharmacogenomics Journal is published by Springer Nature. It's publishing house is located in United Kingdom. Coverage history of this journal is as following: 2001-2024. The organization or individual who handles the printing and distribution of printed or digital publications is known as Publisher.
Visit the official website of the journal/conference to check the further details about the call for papers.
The IS0 4 standard abbreviation of Pharmacogenomics Journal is Pharmacogenomics J.. This abbreviation ('Pharmacogenomics J.') is well recommended and approved for the purpose of indexing, abstraction, referencing and citing goals. It meets all the essential criteria of ISO 4 standard.
ISO 4 (International Organization for Standardization 4) is an international standard that defines a uniform and consistent system for abbreviating serial publication titles and journals.
If your research field is/are related to Pharmacology (Q2); Genetics (Q3); Molecular Medicine (Q3), then please visit the official website of this journal.
The acceptance rate/percentage of any academic journal/conference depends upon many parameters. Some of the critical parameters are listed below.
It is essential to understand that the acceptance rate/rejection rate of papers varies among journals. Some Journals considers all the manuscripts submissions as a basis of acceptance rate computation. On the other hand, few consider the only manuscripts sent for peer review or few even not bother about the accurate maintenance of total submissions. Hence, it can provide a rough estimation only.
The best way to find out the acceptance rate is to reach out to the associated editor or to check the official website of the Journal/Conference.
Pharmacogenomics Journal latest impact IF is 2.86. It's evaluated in the year 2024. The highest and the lowest impact IF or impact score of this journal are 4.77 (2014) and 2.58 (2023), respectively, in the last 11 years. Moreover, its average IS is 3.4 in the previous 11 years.
The Pharmacogenomics Journal has an SJR (SCImago Journal Rank) of 0.694, according to the latest data. It is computed in the year 2025. In the past 11 years, this journal has recorded a range of SJR, with the highest being 1.648 in 2014 and the lowest being 0.621 in 2022. Furthermore, the average SJR of the Pharmacogenomics Journal over the previous 11-year period stands at 3.4.
The latest h-index of the Pharmacogenomics Journal is 99.
The Pharmacogenomics Journal is published by the Springer Nature, with its country of publication being the United Kingdom.
The Pharmacogenomics Journal is currently ranked 8195 out of 27955 Journals, Conferences, and Book Series in the latest ranking. Over the course of the last 11 years, this journal has experienced varying rankings, reaching its highest position of 1964 in 2014 and its lowest position of 8244 in 2022.
The standard ISO4 abbreviation for the Pharmacogenomics Journal is Pharmacogenomics J..
Pharmacogenomics Journal is classified as a journal that the Springer Nature publishes.
The Pharmacogenomics Journal encompasses the following areas:
For a more comprehensive understanding of its scope, check the official website of this journal.
The Pharmacogenomics Journal is assigned the following International Standard Serial Numbers (ISSN): 1470269X, 14731150.
The best quartile for the Pharmacogenomics Journal is Q2 (2024).
The Pharmacogenomics Journal coverage history can be summarized as follows: 2001-2024.
| Journal/Conference/Workshop/Book Title | Type | Ranking | Publisher | h-index | Impact Score |
|---|---|---|---|---|---|
| Historia | journal | 22470 | Universidade Estadual Paulista | 9 | 0.16 |
| Applied Ecology and Environmental Research | journal | 19122 | Corvinus University of Budapest | 48 | 0.84 |
| Proceedings of the International Symposium on Power Semiconductor Devices and ICs | conference and proceedings | 9089 | Institute of Electrical and Electronics Engineers Inc. | 55 | 2.19 |
| Journal of Competition Law and Economics | journal | 11978 | Oxford University Press | 34 | 0.94 |
| Syntax | journal | 2676 | Wiley-Blackwell Publishing Ltd | 35 | 1.10 |
| Metascience | journal | 24313 | Springer Nature | 3 | 0.00 |
| Brazilian Symposium of Computer Graphic and Image Processing | conference and proceedings | 24442 | IEEE Computer Society | 34 | 0.41 |
| Himalayan Geology | journal | 19942 | Wadia Institute of Himalayan Geology | 20 | 0.89 |
| Acta Bioethica | journal | 20953 | Universidad de Chile - Centro Interdisciplinario de Estudios en Bioetica | 12 | 0.43 |
| Brazilian Journal of Physical Therapy | journal | 5241 | Revista Brasileira de Fisioterapia | 56 | 3.05 |
| Year | Impact Score (IS) |
|---|---|
| 2025/2026 | Coming Soon |
| 2024 | 2.86 |
| 2023 | 2.58 |
| 2022 | 2.84 |
| 2021 | 3.23 |
| 2020 | 3.09 |
| 2019 | 2.90 |
| 2018 | 3.36 |
| 2017 | 3.65 |
| 2016 | 3.88 |
| 2015 | 4.27 |
| 2014 | 4.77 |
